Cardinal Health, Inc. (NYSE:CAH) is trading up 20.72% versus 12-month low of 62.31 and stands -12.83% lower from its 1-year peak of $86.29. The consensus price target (PT) of $80.33 means that the market expects Company shares to increase by 7.5% in the short run. The sell-side target prices range from $72 to $97. In the last month the stock has moved in price 6.44%, with a one year change of -2.93%. The last trading session volume compares with the 3.09M average and market worth floats around 24.07B.

Cardinal Health, Inc. (NYSE:CAH) gained 0.62% to reach at the trading price of $75.22 as it is set to release its next quarterly earnings report on February 07, 2017. Cardinal Health, Inc. stock trades in the range of $74.52 to $75.97 before the earnings release. Let’s take a closer look at the current earnings forecast, particularly the things traders should pay close attention to. Earnings per share for the recently concluded quarter is expected to come in at $1.23 a share with $33.64B in revenue.

Cardinal Health, Inc. (CAH) Future Earnings & History

After upcoming fiscal quarter results, all eyes will be on the prospects for the next reporting quarter. Analysts, on average, forecast Cardinal Health, Inc. to earn $1.54 per share (EPS) on revenue of $32.47B. The EPS consensus range is $1.44-$1.59 on revenue between $33.05B and $31.68B.

While if we look at the Earnings Track Record, Cardinal Health, Inc. (CAH) managed to surpass quarterly earnings per share estimates in 12 of the trailing twelve fiscal quarters, and has a positive trend with an average surprise of 100%. Last time the company reported, Cardinal Health, Inc. (CAH) generated $1.24 in earnings per share, beating the consensus estimate of $1.21. Revenues hit $32.04B in the September 2017 quarter, which was above the consensus $31.04B projection. On the other hand, in the June 2017 quarter the company recorded a net $31.38B revenue with earnings per share of $1.14. Wall Street had anticipated $31.19B and $1.13, respectively. For comparison, there was a revenue of $30.66B and EPS of $1.43 in the March 2016 period.

Cardinal Health, Inc. (NYSE:CAH) Analyst Insights

The buoyancy in the outlook of Cardinal Health, Inc. (CAH) is getting weaker by the somewhat negative sentiment (2.50 on a 5-point scale) that sell-side analysts have provided concerning it. Brokerage firms on the average advocate the company shares as Mkt Perform. Leerink Partners has been covering shares of CAH, so it is most recent view is worth a look. In a research note issued on Jan 03, 2017, analysts at downgraded the stock to Neutral from Buy. Another noteworthy analyst activity was recorded on Dec 21, 2016. Downgraded the stock to Mkt Perform from Outperform.